Alkermes plc. — Director's Dealing 2021

Apr 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2021-04-15

Reporting Person: Hopkinson Craig C. (EVP R&D, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-15	Ordinary Shares	S	28920	$19.7195	Disposed	0	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.32 to $19.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.